Inactive Instrument

News Avricore Health Inc Toronto S.E.

Equities

APH

CA92143R2046

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
Avricore Health Corporate Update and Audited Results for 2023	Apr. 30	GL
Avricore Health Inc. - HealthTab Signs Agreement for More Rexall Pharmacy Locations	Apr. 05	AQ
Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations	Apr. 04	MT
HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations	Apr. 04	GL
Avricore Health Provides Update on Q3	Nov. 30	MT
Avricore Health Corporate Update – Company Demonstrates Strong Growth	Nov. 30	GL
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Avricore Health Inc. - HealthTab Supports Patient Testing in the First Rexall Pharmacy Walk-In Clinic	23-09-20	AQ
HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic	23-09-15	GL
Avricore Health Inc. Expands Its Innovative Point-Of-Care Chronic and Infectious Disease Screening and Health- Data Management Platform, Healthtab	23-09-15	CI
Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track	23-08-30	GL
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Avricore's HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom	23-08-09	AQ
Avricore Health Inc. - HealthTab Signs Reseller Agreement with Abbott to Support UK Expansion	23-08-09	AQ
Avricore Health Up Nearly 14% After Reporting Reseller Pact Between HealthTab, Abbott Rapid Dx UK & Ireland	23-08-08	MT
HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion	23-08-08	GL
Avricore Health Inc. Announces its Agreement with Ascensia Diabetes Care to Integrate Their Blood Glucose Monitoring Systems, Marketed as Contour Next Gen and Four Next One	23-08-03	CI
Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom	23-08-03	GL
Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom	23-08-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Avricore Health Inc Toronto S.E.

Equities

APH

CA92143R2046

Summary

Filters